EXPONasdaqServices-Management Consulting ServicesFiscal year ends January 1
EXPONENT INC
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 7, 2026
$72.25+0.40 (+0.56%)
Close on Oct 19, 2026
- Market cap
- $3.54B
- P/E (TTM)
- 32.4
- Dividend yield
- 1.66%
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
20.6%−0.2 pts over 5 years
Net margin
18.2%−2.4 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +4.2% | +4.3% | +7.8% | +6.4% | |
| Operating income | +0.2% | -5.3% | +7.5% | +5.7% | |
| Net income | -2.7% | +1.2% | +5.1% | +9.3% | |
| EPS, diluted | -1.9% | +1.8% | +6.0% | +10.0% | |
| Free cash flow | -11.1% | +14.4% | +4.5% | +8.3% | |
| Dividend per share | +7.1% | +7.7% | +9.6% | +14.9% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 17.7% | 23.2% | 26.1% | |
| Return on assets | 12.0% | 14.4% | 13.6% | |
| Current ratio | 3.42 | 3.13 | 2.40 | |
| Capex to revenue | 4.6% | 1.2% | 1.6% | |
| Diluted shares | 54M | 53M | 51M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Exponent generated $621.99M from operations and spent $607.65M on capital expenditure, dividends and share buybacks. 8% of that went back into the business.
Generated
$621.99M
Used
$607.65M
Capital expenditure$51.55M8%Dividends$266.23M44%Share buybacks$289.87M48%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin18.2%
×Asset turnover0.75×
×Equity multiplier1.92×
=Return on equity, FY202526.1%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 18.2% | 0.75× | 1.92× | 26.1% |
| FY2024 | 19.5% | 0.78× | 1.83× | 28.1% |
| FY2023 | 18.7% | 0.87× | 1.82× | 29.6% |
| FY2022 | 19.9% | 0.81× | 1.72× | 27.7% |
| FY2021 | 21.7% | 0.74× | 1.62× | 26.0% |
| FY2020 | 20.6% | 0.70× | 1.61× | 23.2% |
| FY2019 | 19.8% | 0.81× | 1.55× | 24.8% |
| FY2018 | 19.0% | 0.84× | 1.51× | 24.0% |
| FY2017 | 11.9% | 0.82× | 1.50× | 14.7% |
| FY2016 | 15.1% | 0.80× | 1.48× | 17.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$106.01M
- Cash generatingOperating cash flow above zero$131.73M
- Return on assets improvedROA up on the prior year16.9% → 13.6%
- Earnings backed by cashOperating cash flow above net income$131.73M vs $106.01M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.74 → 2.40
- No dilutionShare count did not rise52M → 51M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.86 → 0.75